Search research articles
Contact Us
Filters
Showing results (31-40 of 46) with videos related to
Page
of 5
Sort By:
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology
|
January 28, 2021
Possible Modulatory Role of ARC Gene Variants in Mood Disorders
Concetta Crisafulli, Marco Calabrò, Laura Mandelli, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology
|
July 30, 2019
Genes Involved in Neurodevelopment, Neuroplasticity and Major Depression: No Association for <i>CACNA1C, CHRNA7</i> and <i>MAPK1</i>
Marco Calabrò, Laura Mandelli, Concetta Crisafulli, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
February 13, 2022
Metabolizing status of CYP2C19 in response and side effects to medications for depression: Results from a naturalistic study
Marco Calabrò, Chiara Fabbri, Siegfried Kasper, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
March 6, 2017
Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance
Chiara Fabbri, Concetta Crisafulli, Raffaella Calati, et al.
Advances in Therapy
|
September 5, 2018
Neuroplasticity, Neurotransmission and Brain-Related Genes in Major Depression and Bipolar Disorder: Focus on Treatment Outcomes in an Asiatic Sample
Marco Calabrò, Laura Mandelli, Concetta Crisafulli, et al.
Journal of the Neurological Sciences
|
October 25, 2016
Role of neurodevelopment involved genes in psychiatric comorbidities and modulation of inflammatory processes in Alzheimer's disease
Stefano Porcelli, Concetta Crisafulli, Luigi Donato, et al.
Current Medicinal Chemistry
|
January 5, 2021
Research Domain Criteria (RDoC): A Perspective to Probe the Biological Background behind Treatment Efficacy in Depression
Marco Calabrò, Chiara Fabbri, Siegfried Kasper, et al.
Psychiatric Genetics
|
February 26, 2025
A machine learning approach to predict treatment efficacy and adverse effects in major depression using CYP2C19 and clinical-environmental predictors
Marco Calabrò, Chiara Fabbri, Alessandro Serretti, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology
|
April 25, 2020
<i>ZNF804A</i> Gene Variants Have a Cross-diagnostic Influence on Psychosis and Treatment Improvement in Mood Disorders
Marco Calabrò, Laura Mandelli, Concetta Crisafulli, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
March 30, 2013
Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients
Raffaella Calati, Concetta Crisafulli, Martina Balestri, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 46) with videos related to
Sort By:
Page
of 5
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology
|
January 28, 2021
Possible Modulatory Role of ARC Gene Variants in Mood Disorders
Concetta Crisafulli, Marco Calabrò, Laura Mandelli, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology
|
July 30, 2019
Genes Involved in Neurodevelopment, Neuroplasticity and Major Depression: No Association for <i>CACNA1C, CHRNA7</i> and <i>MAPK1</i>
Marco Calabrò, Laura Mandelli, Concetta Crisafulli, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
February 13, 2022
Metabolizing status of CYP2C19 in response and side effects to medications for depression: Results from a naturalistic study
Marco Calabrò, Chiara Fabbri, Siegfried Kasper, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
March 6, 2017
Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance
Chiara Fabbri, Concetta Crisafulli, Raffaella Calati, et al.
Advances in Therapy
|
September 5, 2018
Neuroplasticity, Neurotransmission and Brain-Related Genes in Major Depression and Bipolar Disorder: Focus on Treatment Outcomes in an Asiatic Sample
Marco Calabrò, Laura Mandelli, Concetta Crisafulli, et al.
Journal of the Neurological Sciences
|
October 25, 2016
Role of neurodevelopment involved genes in psychiatric comorbidities and modulation of inflammatory processes in Alzheimer's disease
Stefano Porcelli, Concetta Crisafulli, Luigi Donato, et al.
Current Medicinal Chemistry
|
January 5, 2021
Research Domain Criteria (RDoC): A Perspective to Probe the Biological Background behind Treatment Efficacy in Depression
Marco Calabrò, Chiara Fabbri, Siegfried Kasper, et al.
Psychiatric Genetics
|
February 26, 2025
A machine learning approach to predict treatment efficacy and adverse effects in major depression using CYP2C19 and clinical-environmental predictors
Marco Calabrò, Chiara Fabbri, Alessandro Serretti, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology
|
April 25, 2020
<i>ZNF804A</i> Gene Variants Have a Cross-diagnostic Influence on Psychosis and Treatment Improvement in Mood Disorders
Marco Calabrò, Laura Mandelli, Concetta Crisafulli, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
March 30, 2013
Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients
Raffaella Calati, Concetta Crisafulli, Martina Balestri, et al.
Page
of 5